Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

AUTOMATED PROTOTYPE OF CANCER DETECTION FROM CTDNA

Obiettivo

Floating Genes is a French deeptech startup incorporated in October 2021, developing early cancer detection tools from liquid biopsies. The company focuses on digestive cancers, and especially colorectal and pancreatic cancer, which is mostly detected in stage 4 and show 4.3 month of median survival. Floating Genes has developed and patented molecular biology tools to detect very rare circulating tumor DNA (ctDNA) in the blood. This will eventually allow earlier cancer diagnosis, precise monitoring and personalized treatment of patients with cancer. 200,000 lives could be saved every year in Europe with such an earlier diagnosis tool.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-CSA - HORIZON Coordination and Support Actions

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-EIE-2022-SCALEUP-02

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

FLOATING GENES
Contributo netto dell'UE
€ 75 000,00
Indirizzo
4 RUE PIERRE FONTAINE
91058 Evry-Courcouronnes
Francia
PMI
Sì
Regione
Ile-de-France Ile-de-France Essonne
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
Nessun dato